HEB = about $200 Million market cap CTIC = about $800 Million market cap
I think CTIC and HEB are both going places and are good picks and potentially fill an unmet need, but I think in the eye of some investors HEB looks to be a better deal short term since they have FDA decision in a week or so, flu adjuvant for Japan and Italy, etc...
If I remember correctly CTIC has not even submitted any applications to the FDA yet. The only think your waiting on is the MAA. After CTIC submits a NDA and they get close to the PUFDA I can see this well over $2
Some people might disagree, but I say don't look at share price as it can be misleading. Look at market cap and potential market.